Saturday 17 October 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024. In the quarter to June 2026, revenue grew 19.9%, EPS fell 81.6%, free cash flow fell 20.3% and total debt rose 602.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

54.68 1.37 −2.44%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 144×
Fwd P/E: 16.1×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	150.58	40.35	32.65	19.91	+8 more quarters Free account
P/S ratio Full definition →	3.25	3.35	3.54	3.36
P/FCF ratio Full definition →	15.27	14.32	15.90	12.59
P/Operating CF Full definition →	65.84	49.28	114.39	28.21
P/B ratio Full definition →	1.75	1.75	1.87	1.72
Price to Tangible BV Full definition →	14.07	1.87	2.01	1.85
EV/Sales Full definition →	4.22	3.26	3.39	3.24
EV/EBITDA Full definition →	48.35	27.46	22.57	14.45
EV/Operating CF Full definition →	16.78	12.10	13.20	10.96
EV/FCF Full definition →	19.84	13.93	15.24	12.13
Quick Ratio Full definition →	1.16	3.94	3.25	2.84
Current Ratio Full definition →	2.39	5.81	5.21	4.83
Net Debt/EBITDA Full definition →	15.85	(5.44)	38.11	27.62
Debt/Assets Full definition →	35.71%	16.65%	7.86%	7.84%
Debt/Equity Full definition →	0.66	0.23	0.10	0.10
Asset Turnover Full definition →	0.36	0.41	0.44	0.43
Operating CF/Net income Full definition →	3.76	2.09	(2.14)	(11.99)
Capex/Depreciation Full definition →	(0.35)	(1.31)	(2.23)	(2.28)
Interest Coverage Full definition →	1.75	8.67	(16.06)	(18.10)
Research and Development Expense of Revenue Full definition →	20.91%	23.34%	22.00%	52.76%
Selling, General and Administrative Expense of Revenue Full definition →	39.97%	33.71%	51.02%	34.58%
Intangible Assets out of Total Assets Full definition →	0.47	0.05	0.05	0.06
Share Based Compensation of Revenue Full definition →	7.65%	5.67%	5.36%	6.35%
Graham Net Nets Full definition →	(0.13)	0.20	0.21	0.22
Graham Number Full definition →	16.72	31.88	36.05	43.93
Earnings Yield Full definition →	0.66%	2.48%	3.06%	5.02%
Free Cash Flow Yield Full definition →	6.55%	6.98%	6.29%	7.94%
Revenue per Share Full definition →	5.12	3.98	4.56	4.04
Operating CF per Share Full definition →	0.87	1.15	0.52	1.92
Capex per Share Full definition →	(0.18)	(0.11)	(0.22)	(0.18)
Free Cash Flow per Share Full definition →	0.69	1.04	0.29	1.74
Cash per Share Full definition →	4.52	11.55	8.14	7.70
Shareholders Equity per Share Full definition →	32.68	32.27	31.74	31.54
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	32.68	32.27	31.74	31.54
Free Cash Flow Full definition →	133.86	199.73	56.55	334.94
Working Capital Full definition →	2,307.63	3,811.92	3,194.46	3,056.11
Capital Expenditures Full definition →	(34.25)	(20.92)	(43.09)	(33.75)
Net Current Asset Value Full definition →	(1,430.13)	2,226.16	2,446.47	2,296.39
EV/EBIT Full definition →	96.34	33.55	26.69	16.27
Capex to Sales Full definition →	0.03	0.03	0.05	0.04
Price to Operating Income Full definition →	74.15	34.50	27.84	16.90
Other line items
Average Receivables Full definition →	958.45	821.55	784.37	783.91
Average Payables Full definition →	845.02	710.68	683.01	757.05
Average Inventory Full definition →	1,561.35	1,274.03	1,265.77	1,280.76
Average Assets Full definition →	9,589.89	7,869.01	7,291.48	7,233.03
Average Common Equity Full definition →	6,174.40	6,002.78	5,872.49	5,735.05

Fold the line items

Columns are period end dates

Stockrow Weekly